Pfizer`s Viagra Patent Invalidated Due to Failure to Disclose

The Supreme Court of Canada has invalidate Pfizer’s Canadian patent on Viagra, citing the drug-maker’s failure to disclose essential information about the main ingredient, sildenafil citrate, in the original application, which was filed in 1994 and granted in 1998. (CA 2163446) The appellant in the case was generic drug maker Teva Canada Ltd.
 
Pfizer holds several other patents related to Viagra, all of which are listed in the Canadian Drug Patent Register.
Here are a couple of stories from the Globe and Mail:
Editorial
Supreme Court backs Canadian firm’s bid to make generic Viagra
This entry was posted in Disclosure, Drugs, Generics, Pfizer, Pharmaceuticals, Teva. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s